Work

NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4

Year: 2012

Type: article

Source: Nature Immunology

DOI: 10.1038/ni.2239

Authors: Jun Cui, Yinyin Li, Liang Zhu, Dan Liu, Zhou Songyang, Helen Y Wang, Rong-Fu Wang

Institutions: Baylor College of Medicine, Houston Methodist, Texas A&M University

Language: English

Topic: interferon and immune responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institute on Drug Abuse, National Cancer Institute, National Institute of General Medical Sciences

Awards: G1458210841, ENHANCING T CELL THERAPY OF CANCER, G1676104003, G1736252752, G1736293207, G238557638, Regulatory Networks in Human Embryonic Stem Cells, G2817337608, G3341062164, G3556871816, G5345427356, G8133443957, Reversal of regulatory T cell function in prostate cancer, G8910848320, Antigen specificity, suppressive mechanism & regulation of CD4+ regulatory T cell

OpenAlex ID: W2132490889

FWCI: 7.144

Cites: 33

Cited by: 305

Related to: 10